« previous next »
Pages: [1]

Author Topic: (Abst.) Risk of SPMS: A longitudinal study  (Read 95 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Big data in MS: What can be learned from large international observational studies?
« on: August 12, 2019, 06:47:51 am »
An editorial about this study--from Multiple Sclerosis Journal (August 12, 2019), "Big data in MS: What can we learn from large international observational studies such as MSBase?":


https://journals.sagepub.com/doi/full/10.1177/1352458519868982
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
4 Replies
200 Views 		Last post April 11, 2017, 07:11:54 pm
by agate
0 Replies
34 Views 		Last post December 13, 2020, 09:50:14 pm
by agate
0 Replies
33 Views 		Last post June 03, 2021, 08:37:51 pm
by agate
0 Replies
25 Views 		Last post December 18, 2021, 08:51:29 pm
by agate
0 Replies
22 Views 		Last post November 04, 2023, 10:04:01 pm
by agate